CryptoOwly
$ASPI Some thoughts/updated list.
1. No form 4 for todd wider meaning no sale yet. The more tome passes the more it looks like a potential option to sell in next 3 months on news.
2. Insider buying.
3. Cost to borrow x4 in the last week.
4. CMD slide points to multiple potential catalysts later this month(s).
5. ENDRA Life Sciences executed multiple amendments tied to pending merger with Renergen readying groundwork for Q4 listing.
6. QLE confidential s1 submitted November last year. Prior calls implied almost there now. Goldman sachs hosting QLE investor lunch. Potentially testing the water? Incidentally GS lead on potential Westinghouse mega IPO coinciding with...
7. Uranium seasonality - set to kick in this month.
8. Prior indications that work underway on pelindaba test bench (as far back as February). In June Paul stated he expected some results from the test benches in the next few months.
None of this means anything until it does. IMHO only. Nfa. Dyor.
1
12
